about
Defining the heterochromatin localization and repression domains of SALL1A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related geneEctopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemiaCell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemiaInteraction of the developmental regulator SALL1 with UBE2I and SUMO-1Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line.GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AMLThe vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia.An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemiaA mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells.A t(6;12)(q23;p13) results in the fusion of ETV6 to a novel gene, STL, in a B-cell ALL cell line.C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutationsAcute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.The MLL recombinome of acute leukemias in 2013.Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia.Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfectaFHL2 interacts with CALM and is highly expressed in acute erythroid leukemia.ETV6: a versatile player in leukemogenesis.Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemiaRUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemiaDistinct microRNA expression profiles in acute myeloid leukemia with common translocations.Genetic instability in inherited and sporadic leukemias.ABCs of genomics.Altered methylation pattern of the G6 PD promoter in Rett syndrome.Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases.High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia.Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL.The radial nuclear positioning of genes correlates with features of megabase-sized chromatin domains.High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
P50
Q24302366-1AA2947B-A6FC-4FB4-8DE6-1B34B781FD99Q24597804-B8393478-569B-4257-B283-1B9EE9F461AEQ24627258-D9B13544-3534-4A1C-9D04-8566FF36C396Q24633341-21942FCB-8D1F-4A7A-9BF8-384A93C939D2Q28219276-B44D5886-0C7C-49E7-9408-D428B4983722Q30165122-0A36402E-7F8A-48AD-B879-D40960B07622Q30315606-06E5DF43-2395-46C3-9D5C-E13DA213A53CQ33231820-88AF0E45-C72E-45DB-B3D8-0EF4AF4E64FBQ33978907-25E5DF6B-871E-4500-BE2B-CBD632534969Q34072688-A73D85B0-DCBD-4F82-BAC4-4789A5D64D15Q34165389-03EB13F2-1E88-4432-95D2-F91D7E36150DQ34197535-D90AFD12-7CE8-408F-B153-E2A5B18D1787Q34292231-C831FAFD-2205-4203-932A-C937AA071FBCQ34398360-FA50FF83-B945-421C-9938-25F688D924F1Q34420529-E3A80493-72B4-4B76-9EE7-BB36398C9B3EQ34541735-0C8E3AEB-88D5-412C-9986-C5F64F69DD29Q34580828-67DDE1A1-5B62-4EEB-B271-5DC7DFB55A2DQ34651113-355CC550-7B2D-4687-B34C-599D1B6D6390Q35114397-F35628F5-EC9C-43E1-B884-84AFF19E78F1Q35221699-1889CF1E-3064-4D2E-877B-79FD5F4EEB5DQ35668394-7350DD5D-C57B-4C18-8AE5-388F8632AF29Q36096564-CF33D10F-6AF0-4FA3-9BFA-B50EC3CDA340Q36228256-F7E29D5F-67CC-44DF-963F-1E1D9F47CDBEQ36288982-180C95D6-3050-48C4-9EED-02411620FA52Q36662047-286E6351-B72B-44B2-80A5-22EF4ED2F6BFQ36862575-84A5A729-FC50-4CCD-AE78-1C5AB8EB643BQ36925156-791BBB16-0261-452D-8A3F-AC906A9140C2Q36926841-ED39655A-7947-44E9-99A1-6D74A1C36C8FQ37789009-D2237BFF-7F0F-424B-949D-1416E18A157EQ38169651-17BE6793-35D9-48BE-935D-30ED89A73445Q38287952-A20DDC3F-A7C9-4873-8776-95F6B843AEE9Q38320037-00CA8DFE-9CB7-4B32-ACEF-B99050B155D4Q38323401-717E3A4D-86F8-4AA2-B0E5-ED58C1231542Q38347615-E975C62A-B6AD-442B-8462-3F09365CC4E2Q38428506-76C04A31-5B3E-402B-B706-9476FDC50BDDQ38470579-BBCEFC28-1DE8-47C5-A19F-73C175E153E3Q38949575-C3560ADD-BC7C-4F97-B768-8A38D9050957Q39262410-794DDF7F-0A49-4DD0-8734-CFEC1FE0272FQ39512567-61000F77-6033-45E7-AD35-0C037F0AC7F3Q39874787-60E4C4A4-C98D-4052-A302-0C5C72F3250B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefan K. Bohlander
@ast
Stefan K. Bohlander
@en
Stefan K. Bohlander
@es
Stefan K. Bohlander
@nl
Stefan K. Bohlander
@sl
type
label
Stefan K. Bohlander
@ast
Stefan K. Bohlander
@en
Stefan K. Bohlander
@es
Stefan K. Bohlander
@nl
Stefan K. Bohlander
@sl
prefLabel
Stefan K. Bohlander
@ast
Stefan K. Bohlander
@en
Stefan K. Bohlander
@es
Stefan K. Bohlander
@nl
Stefan K. Bohlander
@sl
P106
P1153
7004057073
P21
P31
P496
0000-0002-2202-9088